To investigate whether epigenetic alteration could be extrapolated to CRC, we firstly performed MSP analysis to determine the methylation status in the promoter regions of FBLN1 in CRC tissues and adjacent nontumor tissues. This evidence concerns the gene FBLN1 and colorectal carcinoma.